April 9, 2024 April 9, 2024Categories From the Co-ChairsFrom the Co-Chairs, April 2024A new trial in glioblastoma; leadership transitions; upcoming Group Meeting highlights
April 11, 2024 April 11, 2024Categories Active Clinical TrialsNow Enrolling: EAF223/GABLE for Patients with GlioblastomaThis phase 2 imaging biomarker trial is evaluating whether novel biomarkers can accurately identify which patients will have better vs. worse survival outcomes early in their disease course